Preview: India's Max Healthcare rises ahead of earnings on hopes expansion will boost revenue

Max Healthcare Institute

30/10/2026 04:48

** Shares of India's Max Healthcare Institute MAXE.NS inch up 0.58% to 855.9 rupees before quarterly results
** Analysts on average expect Q2 revenue to rise 41.4% year-on-year to 30.2 billion rupees ($317.26 million)--data compiled by LSEG
** Kotak Institutional Equities expects higher occupancy and bed additions to drive Q2 revenue growth, but sees margins falling 160 bps y/y as newer units operate at lower profitability; expects Q2 profit to fall 25.2% y/y
** Jefferies expects revenue to grow 17% y/y, aided by new facility and acquisition, while EBITDA is seen rising 14%; expects Q2 profit to fall 22% 
** Motilal Oswal expects higher volumes to support earnings, but flags slower occupancy ramp-up and the halt of certain chemotherapy drugs sales
** MAXE rated "buy" by 25 analysts, median PT at 1,160 rupees--data compiled by LSEG
** YTD stock down 18.34%


($1 = 95.1900 Indian rupees)

 (Reporting by Surbhi Misra in Bengaluru)
 ((Surbhi.Misra@thomsonreuters.com |  X: https://twitter.com/SurbhiMisra_  |;))